| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Income - EUR | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Expenses - EUR | 86 | 83 | 70 | 74 | 7 | 0 | 134 | 58 | 323 | 394 |
| Gross Profit/Loss - EUR | -86 | -83 | -70 | -74 | -7 | 0 | -134 | -58 | -323 | -394 |
| Net Profit/Loss - EUR | -86 | -83 | -70 | -74 | -7 | 0 | -134 | -58 | -323 | -394 |
| Employees | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Check the financial reports for the company - Alcons Bio Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 21 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Current Assets | 67.039 | 66.293 | 65.102 | 63.833 | 62.590 | 61.403 | 34.639 | 34.688 | 34.664 | 34.478 |
| Inventories | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | 66.966 | 66.284 | 65.019 | 63.826 | 62.590 | 61.403 | 34.015 | 34.120 | 34.017 | 33.827 |
| Cash | 72 | 10 | 83 | 8 | 0 | 0 | 624 | 567 | 647 | 651 |
| Shareholders Funds | 66.869 | 66.104 | 64.916 | 63.651 | 62.411 | 61.227 | 34.467 | 34.515 | 34.088 | 33.503 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | 191 | 189 | 186 | 183 | 179 | 176 | 172 | 172 | 576 | 975 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "7022 - 7022" | |||||||||
| CAEN Financial Year |
7022
|
|||||||||
Comments - Alcons Bio Srl